2022 Advanced Therapies Week Audiogram

Live from Phacilitate’s 2022 Advanced Therapies Week in Miami, Florida

Take a moment to watch the audiogram of Cate Dyer, CEO & Founder of StemExpress, speak on the importance of partnerships in cell therapy at Phacilitate’s 2022 Advanced Therapies Week.

Picking the Right Partner from Product and Process Development Through Commercialization

  • Qualifying how you choose your raw and starting material provider
  • Increase your commercialization success rates through standardized methods, access to a diverse and recallable donor pool, and reduce outcome variability
    • Choosing a complete partner for primary source material for research use, pre-clinical evaluation, and clinical GMP compliant cellular products
advanced therapies week
Cate Dyer, CEO & Founder of StemExpress
advanced therapies week

Signup for StemExpress Alerts

Newsletter Sign Up

By signing up you are agreeing to receive news, offers and information from StemExpress. Click here to visit our Privacy policy. You can unsubscribe at any time.
Select emails you’d like to receive:
Consent
Consent
This field is for validation purposes and should be left unchanged.